Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Alejandro Lemor, MD: A-SMART-EF Score

Alejandro F. Lemor, MD, disusses A-SMART-EF, a new risk score for predicting outcomes in patients supported with Impella® during PCI.

Bill O’Neill: High-Risk PCI and Use of MCS

William O’Neill, MD, defines high-risk PCI and explains how to decide when to use mechanical circulatory support in this short interview.

Vandenbriele Letter: “We Need More Pieces of the Puzzle”

Prof. Christophe Vandenbriele, MD, urges caution and the need for context when drawing conclusions from retrospective analyses in critically ill patients with cardiogenic shock.

Renal Protection and Hemodynamic Improvement by Impella® Heart Pumps

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

Optimized Patient Selection for High-Risk Protected PCI

Jürgen Leick, MD, discusses his paper on optimizing patient selection in high-risk protected percutaneous coronary intervention.

Vandenbriele: Anticoagulation and Protected PCI

Prof. Dr. Christophe Vandenbriele discusses his recently published paper on anticoagulation in patients underoing Protected PCI procedures.

Karim Ibrahim: Handling High-Risk Patients in the Cath Lab

Prof. Karim Ibrahim discusses his article describing best practices for handling high-risk patients in the cardiac catheterization laboratory.

ESC 2023: Predictors of 90-Day Outcomes From York Analysis

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

York Data Analysis About Complete Revascularization With pVAD vs IABP: Part I vs Part II - A Comparison

Learn more about the data and differences between part I and part II from the York data analysis.

Acute Coronary Syndromes and High-Risk PCI: State of the Art - Predictive Value of Residual Syntax Score for Clinical Outcomes After High-Risk Percutaneous Coronary Intervention

In the presentation titled “Predictive value of residual SYNTAX score for clinical outcomes after high-risk percutaneous coronary intervention: Evidence from pooled analysis of prospective studies.”

Revascularization Completeness With pVAD vs IABP

In a third-party analysis conducted by the York Health Economics Consortium, IPD from contemporary studies were evaluated to test the hypothesis that PCI with Impella® support may be associated with a greater extent of revascularization.

A “Treasure Trove” of Complete Revascularization Data

Vasileios Panoulas, MD, discusses an individual patient data pooling from the PROTECT II RCT, PROTECT III and RESTORE EF trials released at EuroPCR 2023.

Subanalysis of Women in IMP-IT Registry

Alaide Chieffo, MD, discusses results from a subanalysis of women in the IMP-IT Registry in Italy.

Can I Bill for Daily Management of Impella®?

Are there billable services after Impella® insertion in the cath lab, such as ICU monitoring?

REVIVED-BCIS2 Interview: Gregg Stone and Divaka Perera

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].